⌘K

Login Start Free

Home/Filings/4/0001415889-25-008715

4//SEC Filing

SMITH IAN F 4

Accession 0001415889-25-008715

CIK 0001623526other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:19 PM ET

Size

5.5 KB

Accession

0001415889-25-008715

Insider Transaction Report

Form 4

Period: 2025-03-20

Stoke Therapeutics, Inc.STOK

DirectorInterim CEO

Transactions

Award
Stock Option (Right to Buy)
2025-03-20+238,420→ 238,420 total
Exercise: $8.33Exp: 2035-03-19→ Common Stock (238,420 underlying)

Footnotes (1)

[F1]The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.

Documents

1 file

4
form4-03202025_100340.xmlPrimary

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1

filerCIK 0001197032

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 6:19 PM ET
Size: 5.5 KB

View on SEC.gov